Investigating furosemide treatment strategies for severe bronchopulmonary dysplasia in infants
Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy
This study is looking at how different amounts and lengths of a medicine called furosemide can help improve the health of premature babies with a serious lung condition called bronchopulmonary dysplasia (BPD).
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10893331 on NIH RePORTER |
What this research studies
This research focuses on improving treatment strategies for infants suffering from severe bronchopulmonary dysplasia (BPD), a serious lung condition often seen in premature babies. The study aims to evaluate the effectiveness of different dosages and durations of furosemide, a diuretic medication, to enhance outcomes for these vulnerable patients. By utilizing a patient-oriented approach, the research will gather data on how these treatment strategies impact the health and recovery of infants with severe BPD. The project also emphasizes mentorship and training for the lead investigator to foster future independent research in pediatric care.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature infants diagnosed with severe bronchopulmonary dysplasia.
Not a fit: Patients who are not premature or do not have a diagnosis of severe bronchopulmonary dysplasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment protocols for infants with severe bronchopulmonary dysplasia, potentially improving their long-term health outcomes.
How similar studies have performed: Previous research has shown promising results with similar treatment strategies for bronchopulmonary dysplasia, indicating potential for success in this approach.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Bamat, Nicolas Augusto — Children's Hosp of Philadelphia
- Study coordinator: Bamat, Nicolas Augusto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.